In this episode of The Wellness Verdict, Whitney sits down with Gretch Elizabeth, co-founder of NeverTox, to discuss the lesser-known risks associated with Botox and the broader conversation around toxin safety. Gretch shares the personal story behind NeverTox—her sister Heidi’s severe, long-term reaction to Botox that was initially misdiagnosed as anxiety. She explains how this experience led her and her sister to create a support network for individuals and providers navigating adverse reactions to botulinum toxin treatments.

Drawing from research and community insights, Gretch discusses topics like the FDA’s recommended Botox limits compared to real-world usage, how injuries are reported, and gaps in existing safety data. She also explores potential links between Botox and Mast Cell Activation Syndrome (MCAS), considerations for people with autoimmune conditions, and symptoms that may signal Botox poisoning. They touch on the limited availability of the botulinum antitoxin, the critical time frame for its use, and how treatment decisions are made. Gretch shares what she’s learned from her support group about recovery strategies and the possible long-term presence of Botox in the body.

Key Topics Covered:

• Heidi’s story: A severe reaction to Botox misdiagnosed as anxiety
• FDA safety limits vs. real-world Botox usage
• How injuries and adverse reactions are reported (and underreported)
• Botox’s link to MCAS and autoimmune considerations
• Symptoms of Botox poisoning and when antitoxin is needed
• Support groups for patients and providers
• Long-term presence of Botox in the body and recovery methods

This conversation sheds light on the often-overlooked risks of Botox and empowers listeners to make more informed decisions about non-toxic living.

Follow Gretch Elizabeth
instagram.com/nevertox
threads.com/nevertox
tiktok: @nevertox
www.toxsafety.com - web
youtube.com/@nevertox
https://www.facebook.com/groups/224009391310103 - support group